Inventor · disambiguated record
Jens Breinholt
Also filed as: BREINHOLT JENS
28 granted patents·13 pending applications·265 citations·filing 1991–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0192US11325983B2Bispecific antibodiesNOVO NORDISK AS·Filed 2021·Granted May 10, 2022·2 cites·9 claims
- 0292US6407086B2Meiosis regulating compoundsNOVO NORDISK AS·Filed 2001·Granted Jun 18, 2002·53 cites·8 claims
- 0392US6039942APhytase polypeptidesNOVO NORDISK AS·Filed 1997·Granted Mar 21, 2000·71 cites·15 claims
- 0490US8361469B2Antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2009·Granted Jan 29, 2013·17 cites·4 claims
- 0588US6884796B2Meiosis regulating compoundsSCHERING AG·Filed 2002·Granted Apr 26, 2005·29 cites·7 claims
- 0684US9896513B2Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2014·Granted Feb 20, 2018·7 cites·20 claims
- 0775US8513192B2Stable growth hormone compounds resistant to proteolytic degradationOLSEN OLE HVILSTED·Filed 2010·Granted Aug 20, 2013·4 cites·14 claims
- 0875US2025002607A1Bispecific antibodiesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0974US12122847B2Factor VII (FVII(a))/TREM-like transcript 1 (TLT-1) bispecific antibodiesNOVO NORDISK AS·Filed 2022·Granted Oct 22, 2024·0 cites·6 claims
- 1067US5871966AEnzyme with endo-1,3(4)-β- Glucanase activityNOVO NORDISK AS·Filed 1995·Granted Feb 16, 1999·33 cites·16 claims
- 1166US11135275B2Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plateletsNOVO NORDISK AS·Filed 2018·Granted Oct 5, 2021·0 cites·6 claims
- 1262US2019211112A1Antibodies Against Tissue Factor Pathway InhibitorNOVO NORDISK AS·Filed 2019·Application pending·0 cites
- 1360US9574011B2Antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2012·Granted Feb 21, 2017·0 cites·13 claims
- 1459US10106606B2Targeting tissue factor to activated plateletsNOVO NORDISK AS·Filed 2016·Granted Oct 23, 2018·0 cites·12 claims
- 1559US8652471B2Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2012·Granted Feb 18, 2014·0 cites·19 claims
- 1659US2019062429A1Targeting tissue factor to activated plateletsNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 1759US2005101573A1Meiosis regulating compoundsSCHERING AG·Filed 2004·Application pending·0 cites
- 1856USRE39678EMeiosis regulating compoundsSCHERING AG·Filed 2004·Granted Jun 5, 2007·0 cites·8 claims
- 1956US6140096AEnzyme with endo-1,3(4)-β-glucanase activityNOVO NORDISK AS·Filed 1998·Granted Oct 31, 2000·22 cites·22 claims
- 2056US2017114147A1Antibodies Against Tissue Factor Pathway InhibitorNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 2154US10717784B2Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2018·Granted Jul 21, 2020·0 cites·10 claims
- 2254US7238350B2Phytase polypeptidesNOROZYMES AS·Filed 2001·Granted Jul 3, 2007·0 cites·25 claims
- 2349US2016263230A1Coagulation Factor-Targeting to TLT-1 on Activated PlateletsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2449US2010292444A1Novel Prolactin CompoundsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2549US2013337537A1Coagulation factor-targeting to tlt-1 on activated plateletsHILDEN IDA·Filed 2012·Application pending·0 cites
- 2648US6060298APeniophora phytaseNOVO NORDISK AS·Filed 1997·Granted May 9, 2000·9 cites·11 claims
- 2747US2012178908A1Targeting tissue factor to activated plateletsHILDEN IDA·Filed 2010·Application pending·0 cites
- 2845US2010249029A1Peptides with high affinity for the prolactin receptorNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2944US6569659B1Phytase polypeptidesNOVOZYMES AS·Filed 2000·Granted May 27, 2003·0 cites·21 claims
- 3044US5654271AFungicidally active compoundsNOVO NORDISK AS·Filed 1995·Granted Aug 5, 1997·4 cites·16 claims
- 3144US5596015AFungicidally active compoundsNOVO NORDISK AS·Filed 1994·Granted Jan 21, 1997·3 cites·23 claims
- 3239US2016024487A1Thrombin sensitive coagulation factor x moleculesNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 3337US11279771B2Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)NOVO NORDISK AS·Filed 2015·Granted Mar 22, 2022·0 cites·6 claims
- 3437US6054306APeniophora phytaseNOVO NORDISK AS·Filed 1998·Granted Apr 25, 2000·4 cites·5 claims
- 3536US5514648AFungicidally active compoundsNOVO NORDISK AS·Filed 1991·Granted May 7, 1996·1 cites·7 claims
- 3636US2013323259A1Il-21 ligandsSVENSSON LARS ANDERS·Filed 2012·Application pending·0 cites
- 3735US5646110AFungicidally active compoundsNOVO NORDISK AS·Filed 1995·Granted Jul 8, 1997·1 cites·19 claims
- 3835US2014170153A1Il-21 epitope and il-21 ligandsSVENSSON ANDERS·Filed 2012·Application pending·0 cites
- 3932US5641804AFungicidal compound comprising a cyclic polylactoneNOVO NORDISK AS·Filed 1993·Granted Jun 24, 1997·5 cites·23 claims
- 4031US5631223AFungicidally active compoundsNOVO NORDISK AS·Filed 1995·Granted May 20, 1997·0 cites·10 claims
- 4124US6172006B1Furyl-pyridone compounds, useful as fungicides and obtained from the fungus CladobotryumNOVO NORDISK AS·Filed 1998·Granted Jan 9, 2001·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Jens Breinholt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →